This holiday season will be a “bloodbath” for retailers, according to Marc Lichtenfeld. But there are still some companies that will dodge the downtrend. Marc says Kohl’s (NYSE:KSS), Wal-Mart (NYSE:WMT) and Dollar Tree (Nasdaq:DLTR) are well placed to weather the crisis. And they could even benefit from the demise of the competition.
Marc Lichtenfeld at The Smart Profits Report says he’s found an “immense” investment opportunity in a small-cap biotech firm.
There are three entry points in biotech stocks. They are: The first stages of research for a new drug; the initial human trial phases; and immediately before the drug is FDA approved. The later the entry point, the safer the investment.
The stock Marc has his eye on is a late-stage company. It is finishing Phase III trials for a unique cancer treatment drug which, if successful, will corner an entire market.
Investing in biotech stocks can be incredibly rewarding, financially and personally, says Marc Lichtenfeld writing in Investment U. However, timing is crucial to success. Here, Marc walks investors through the three phases of the drug development process…
Former Soviet republic Georgia is in turmoil. Eyewitness say villages are being burned and looted as Russian tanks and soldiers advance from the breakaway province of South Ossetia.
But the markets remain relatively unmoved by the fighting in the Caucasus. In particular, oil and gold remain low.
That’s because markets do not respond to macro events, says Marc Licthenfeld in The Smart Profits Report. It’s just the opposite: The market is an excellent predictor of economies and world events, with the economy typically following the market’s lead six to nine months later. More from Marc…
Blindly following stock tips from Wall Street analysts is a bad idea, says Marc Lichtenfeld in The Smart Profits Report. For most investment bankers, drumming up business and trading commissions is more of a priority than getting every forecast right. Finding a quality company that Wall Street ignores is a surefire way to book considerable profits. More from Marc…
What They’re Saying About The Financial Sector Sounds Nice… As I was running to catch my early morning flight on Saturday, I grabbed a copy of the New York Times and Barron’s. I looked at the Barron’s cover and figured that I must not have gotten enough sleep and was still in dreamland.
“The U.S. bear market has deepened,” says The IHT.
Even helicopter Ben is worried. He’s told Congress that inflation risks have “intensified” and that there’s now a threat of “significant downside” to growth.
But contrarian investors should be lapping it up, says Marc Lichtenfeld in The Smart Profits Report. A bear market is where bargains are made.
Marc has put together a list of stocks that performed well in during the last bear… and four stocks that are currently battling the bear head on…
We’ve published a lot lately on Washington’s efforts to intervene in the oil markets to bring down crude oil and gas prices.
Most strident is former Democrat and now independent Connecticut senator Joseph Lieberman. Lieberman wants to ban private and public pension funds with over $500 million in assets from investing in commodities traded on a US futures exchange, foreign exchange or over the counter.
Problem is Lieberman’s ally in the attempt to curb the speculators thinks his plan stinks.
It can often be quite a lonely place and the investment crowd may call you all kinds of derogatory names - but when it comes to stock picking, nothing beats the feeling of striking out on your own, going against conventional wisdom and being proved correct.